Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Visible Genetics Inc. (NasdaqNM:VGIN)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | Msgs | Insider | Options
Recent Events
Aug  9Earnings Announcement
Location
700 Bay Street, Ontario M5G 1Z6
Toronto, Canada
Phone: (416) 813-3240
Fax: (416) 813-3250
Email: bruno@visgen.com
Employees (last reported count): 341
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Technology
 ·Industry: Scientific & Technical Instr.
Company Websites
 ·Home Page
 ·Investor Relations
 ·Products & Services
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 44%
·Institutional: 48% (86% of float)
(67 institutions)
·Net Inst. Buying: 467.0K shares (+5.56%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Visible Genetics Inc. develops, manufactures and sells integrated DNA sequencing systems that analyze genetic information to improve the treatment of selected diseases. The Company's strategy is to become a leader in the emerging field of pharmacogenomics, the science of individualizing therapy based on genetic differences across patients. Visible Genetics' genotyping technology, which employs DNA sequencing, enables the analysis, in the clinical diagnostic laboratory, of individual genetic variations. The Company believes that individualizing therapy through pharmacogenomics will improve the treatment of many diseases, such as those caused by Human Immunodeficiency Virus (HIV), hepatitis B, hepatitis C, tuberculosis and eventually some cancers.
More from Market Guide: Expanded Business Description

Financial Summary
Visible Genetics Inc. develops, manufactures and markets automated DNA sequencing systems and provides genotyping testing services for HIV and other diseases. For the six months ended 6/30/01, sales increased 6% to $7.5 million. Net loss applicable to Common increased 28% to $19.6 million. Revenues reflect increased sequencing systems sales. Higher loss reflects higher personnel-related and R&D expenses, and $540 thousand in exit and termination costs.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Richard Daly, 51
Pres, CEO
$351K
Thomas Clarke, 52
CFO
159K
Timothy Ellis, 53
COO
180K
Arthur Cole Dr., 50
Exec. VP; Pres, Visible Genetics Europe S.A.
208K
Marguerite Ethier, 37
VP, Gen. Counsel, Director
142K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:VGINAs of 31-Aug-2001
Price and Volume
52-Week Low
on 12-Apr-2001
$12.16 
Recent Price$26.60 
52-Week High
on 14-Sep-2000
$48.75 
Beta0.94 
Daily Volume (3-month avg)181.0K
Daily Volume (10-day avg)143.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-43.7%
52-Week Change
relative to S&P500
-24.5%
Share-Related Items
Market Capitalization$436.2M
Shares Outstanding16.4M
Float9.20M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$3.57 
Earnings (ttm)-$2.47 
Earnings (mrq)-$0.62 
Sales (ttm)$0.84 
Cash (mrq)$3.11 
Valuation Ratios
Price/Book (mrq)7.45 
Price/EarningsN/A 
Price/Sales (ttm)31.69 
Income Statements
Sales (ttm)$13.5M
EBITDA (ttm)-$33.5M
Income available to common (ttm)-$39.8M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-33.01%
Return on Equity (ttm)-52.66%
Financial Strength
Current Ratio (mrq)5.87 
Debt/Equity (mrq)0 
Total Cash (mrq)$51.0M
Short Interest
As of 8-Aug-2001
Shares Short1.43M
Percent of Float15.5%
Shares Short
(Prior Month)
1.36M
Short Ratio9.86 
Daily Volume145.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.